Summary. Treatment of preimplantation mouse embryos in vitro with 10\ p=n-\ 3 to 10\ p=n-\ 1\ g=m\ g actinomycin D/ml for 2 hr showed that (i) (BSS) and were cultured in modified Eagle's basal medium (BME) (Goldstein et al, 1975) .
Summary. Treatment of preimplantation mouse embryos in vitro with 10\ p=n-\ 3 to 10\ p=n-\ 1\ g=m\ g actinomycin D/ml for 2 hr showed that (i) postimplantation development in vitro was inhibited most when embryos were treated at the morula stage and (ii) after the morula stage actinomycin D inhibited trophoblast outgrowth less than inner cell mass development.
Treatment of preimplantation mouse embryos with actinomycin D inhibits their preimplantation development in vitro (Skalko & Morse, 1969) and can cause developmental anomalies (TuchmannDuplessis & Mercier-Parot, 1960) . It also impairs the capacity of the embryos for postimplantation development. When blastocysts are incubated briefly with 10_3-10_1 µg actinomycin D/ml and then transferred to pseudopregnant mice, fewer implant and develop into live fetuses than controls (Bell & Glass, 1975) . When blastocysts are incubated continuously or for 24 hr with 5 IO-3 µg actinomycin D/ml and their postimplantation development in vitro is assessed, trophoblast outgrowths are formed but inner cell masses are not (Rowinski, Solter & Koprowski, 1975 Randomly bred 6-to 10-week-old Dub: (ICR) mice (Flow Research Animals, Inc., Dublin, Virginia) were induced to superovulate and were mated as described previously (Goldstein, Spindle & Pedersen, 1975) . The day the plug was found was designated as Day 1 of pregnancy. The embryos were flushed from the oviducts and uteri on Day 3 (morulae) and from the uteri on Day 4 (early blastocysts) or Day 5 (late blastocysts, i.e. only those without a zona pellucida) with modified Hanks' balanced salt solution (BSS) and were cultured in modified Eagle's basal medium (BME) (Goldstein et al, 1975) .
A stock solution of actinomycin D (Calbiochem, La Jolla, California) was made with distilled water at a concentration of 10 µg/ml, kept at 4°C in the dark, and diluted to appropriate concentrations in modified BME before use. Embryos were incubated for 2 hr in medium containing actinomycin D, washed 5 times in modified Hanks' BSS, and transferred to 8-chamber culture slides (Lab Tek, Naperville, Illinois) containing modified BME. They were allowed to grow for 6 days (morulae), 5 days (early blastocysts) or 4 days (late blastocysts). The response of the embryos to actinomycin D treatment was evaluated at the end of the culture period by counting the number of embryos that developed to the following postimplantation endpoints: (1) trophoblast outgrowth, (2) growth of a well defined inner cell mass on the trophoblast outgrowth, and (3) development of this inner cell mass into 2 germ layers (endoderm and ectoderm) recognizable under the dissecting microscope.
Each treatment was repeated 4-12 times and the combined results were analysed with the 2 test for significant differences (1 d.f., <0-05 or <0-01). The results (Table 1) show that postimplantation development of mouse embryos was most in¬ hibited by actinomycin D when embryos were treated at the morula stage. At this stage inhibition of inner cell mass growth and trophoblast outgrowth was not significantly different at any dose, al¬ though at 10"2 µg/ml development to 2 layers was slightly more inhibited than trophoblast outgrowth. When early blastocysts were treated with 10"1 µg actinomycin D/ml, both growth of the inner cell mass and development to 2 layers were more inhibited than trophoblast outgrowth. When late blastocysts were treated with 10" ' µg actinomycin D/ml, only inner cell mass growth and develop¬ ment to 2 layers were inhibited.
The primary effect of actinomycin D in mouse embryos is inhibition of RNA synthesis (Monesi, Molinaro, Spalleta & Davoli, 1970; Tasca & Hillman, 1970; Golbus, Calarco & Epstein, 1973) , especially ribosomal RNA synthesis (Pikó, 1970) , which in turn impairs protein synthesis. For example, a dose of 10" * µg/ml almost completely inhibits RNA synthesis and reduces protein synthesis by 20% (Monesi et al, 1970 (Pedersen & Spindle, 1976 
